Main menu button

News

Equity Research Candles Scandinavia Q1 2023/24: Cautious customers
30 aug 2023
Equity Research Candles Scandinavia Q1 2023/24: Cautious customers
Equity Research Candles Scandinavia
Equity Research Svenska Aerogel, Q2 2023: Lower than expected revenues but positive development with key customers
30 aug 2023
Equity Research Svenska Aerogel, Q2 2023: Lower than expected revenues but positive development with key customers
Equity Research Svenska Aerogel
Carlsquare weekly market letter: September is Christmas for traders
30 aug 2023
Carlsquare weekly market letter: September is Christmas for traders
Equity Research Carlsquare
Candles Scandinavia: CEO interviewed on the Q1 2023/2024-report
28 aug 2023
Candles Scandinavia: CEO interviewed on the Q1 2023/2024-report
Equity Research Candles Scandinavia
Initiation of coverage Nosa Plugs: Smelling success, plugging a hole in the market
28 aug 2023
Initiation of coverage Nosa Plugs: Smelling success, plugging a hole in the market
Equity Research Nosa Plugs
Equity Research Zazz Energy, Q2 2023: Intense quarter and restart expected soon
25 aug 2023
Equity Research Zazz Energy, Q2 2023: Intense quarter and restart expected soon
Equity Research
Equity research Observit, Q2 2023: Strong performance from software company
24 aug 2023
Equity research Observit, Q2 2023: Strong performance from software company
Equity Research Observit
Equity Research Zazz Energy, Q2 2023: Intensive quarter awaiting the restart of the Amfilochia plant
23 aug 2023
Equity Research Zazz Energy, Q2 2023: Intensive quarter awaiting the restart of the Amfilochia plant
Equity Research
Equity Research, Pharmiva: Merger with Peptonic could spark the fire
23 aug 2023
Equity Research, Pharmiva: Merger with Peptonic could spark the fire
Equity Research
Carlsquare weekly market letter: China and the US are dithering. The boat is rocking
23 aug 2023
Carlsquare weekly market letter: China and the US are dithering. The boat is rocking
Equity Research Carlsquare
Equity research Observit, Q2 2023: Strong performance from software company
22 aug 2023
Equity research Observit, Q2 2023: Strong performance from software company
Equity Research Observit
Equity research update Kancera: Heart infarction results expected soon
22 aug 2023
Equity research update Kancera: Heart infarction results expected soon
Equity Research Kancera
Research Update InCoax, Q2 2023: A potential new Tier 1 operating customer
21 aug 2023
Research Update InCoax, Q2 2023: A potential new Tier 1 operating customer
Equity Research InCoax
Research Update Ecoclime, Q2 2023: Sales growth much better than expected
18 aug 2023
Research Update Ecoclime, Q2 2023: Sales growth much better than expected
Equity Research
First Impression InCoax, Q2 2023: Sales lower than expected, but good gross margin
18 aug 2023
First Impression InCoax, Q2 2023: Sales lower than expected, but good gross margin
Equity Research InCoax
Equity research Risk Intelligence, Q2 2023: A strong quarter throughout
18 aug 2023
Equity research Risk Intelligence, Q2 2023: A strong quarter throughout
Equity Research Risk Intelligence
First Impression Ecoclime, Q2 2023: 34% higher revenues than expected
17 aug 2023
First Impression Ecoclime, Q2 2023: 34% higher revenues than expected
Equity Research
Research Update Biosergen, Q2 2023: Stable in costs but delays in clinical timeline
16 aug 2023
Research Update Biosergen, Q2 2023: Stable in costs but delays in clinical timeline
Equity Research Biosergen
Equity Research Risk Intelligence, Q2 2023: Better than expected revenues and profitability
16 aug 2023
Equity Research Risk Intelligence, Q2 2023: Better than expected revenues and profitability
Equity Research Risk Intelligence
Carlsquare weekly market letter: The market breaks downwards
16 aug 2023
Carlsquare weekly market letter: The market breaks downwards
Equity Research Carlsquare